Turn Your Attention to Stimulants: A Focus on Trends, Data, Management, and a Provider View
Pricing: Free for members and $30 for non-members
Course Description
Stimulant misuse and overdoses are rising. In 2020, the National Institute on Drug Abuse (NIDA) report 10.3 million people in the U.S. abuse or misuse central nervous system (CNS) stimulants. Between 1999 and 2020, overdose deaths involving stimulants have risen more than 4,000%. With the growing use and misuse, health plans are challenged with managing this class appropriately. Providers are seeing more patients for stimulant use disorder while compelling evidence for treatments for this disease remain scarce.
This session will highlight trends in the use of stimulants nationally, discuss concerns pertaining to stimulant misuse and overdose data, as well as one health plan’s approach to management. A provider will speak about trends in a local health care system, how patients present, and emerging treatments. If you aren’t paying attention to stimulant use disorder, now is the time to focus.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Discuss stimulant use disorder and the trends in national and state-specific data.
- Review a health plan’s assessment and approach to management.
- Describe a provider’s view on stimulant use disorder and the gaps in care and treatment.
Faculty
Ashley N. Chiara, PharmD, MBA, BCPS
Clinical Consultant Pharmacist
UMass Chan Medical School - Commonwealth Medicine, Clinical Pharmacy Services
Chelmsford, MA
Kimberly Lenz, PharmD, MBA, FAMCP
Senior Director of Pharmacy
University of Massachusetts Chan Medical School - Commonwealth Medicine, Office of Clinical Affairs/MassHealth
Quincy, Massachusetts
Moderator
Joel Abraham, PharmD
Pharmacy Resident
Healthfirst
New York, New York
Financial Relationship Disclosures
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Ashley Chiara, PharmD, MBA, BCPS Faculty | Disclosed no relevant financial relationships. |
Kimberly Lenz, PharmD, MBA, FAMCP Faculty | Disclosed no relevant financial relationships. |
Amy Lugo, PharmD, BCPS, BC-ADM, FAPhA | Disclosed no relevant financial relationships. |
Brittany V. Henry, PharmD, MBA Planner | Disclosed no relevant financial relationships. |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-22-033-H04-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: October 12, 2022 • Expiration Date: December 31, 2023
Activity Fee: Free for Members and $30 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2022. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.25 Certificate of Completion